Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis

Márcio Debiasi, Carisi A. Polanczyk, Patrícia Ziegelmann, Carlos Barrios, Hongyuan Cao, James J. Dignam, Paul Goss, Brittany Bychkovsky, Dianne M. Finkelstein, Rodrigo S. Guindalini, Paulo Filho, Caroline Albuquerque, Tomás Reinert, Evandro de Azambuja, Olufunmilayo Olopade

Open source

DOI: 10.3389/fonc.2018.00156
Published: 2018-05-22
Container: Frontiers in Oncology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2018.00156,
  title = {Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis},
  author = {Márcio Debiasi and Carisi A. Polanczyk and Patrícia Ziegelmann and Carlos Barrios and Hongyuan Cao and James J. Dignam and Paul Goss and Brittany Bychkovsky and Dianne M. Finkelstein and Rodrigo S. Guindalini and Paulo Filho and Caroline Albuquerque and Tomás Reinert and Evandro de Azambuja and Olufunmilayo Olopade},
  year = {2018},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2018.00156},
  url = {https://doi.org/10.3389/fonc.2018.00156}
}

RIS

TY  - JOUR
TI  - Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis
AU  - Márcio Debiasi
AU  - Carisi A. Polanczyk
AU  - Patrícia Ziegelmann
AU  - Carlos Barrios
AU  - Hongyuan Cao
AU  - James J. Dignam
AU  - Paul Goss
AU  - Brittany Bychkovsky
AU  - Dianne M. Finkelstein
AU  - Rodrigo S. Guindalini
AU  - Paulo Filho
AU  - Caroline Albuquerque
AU  - Tomás Reinert
AU  - Evandro de Azambuja
AU  - Olufunmilayo Olopade
PY  - 2018
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2018.00156
UR  - https://doi.org/10.3389/fonc.2018.00156
ER  -

APA

Debiasi, M., Polanczyk, C. A., Ziegelmann, P., Barrios, C., Cao, H., Dignam, J. J., Goss, P., Bychkovsky, B., Finkelstein, D. M., Guindalini, R. S., Filho, P., Albuquerque, C., Reinert, T., Azambuja, E. D., & Olopade, O. (2018). Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis. Frontiers in Oncology. https://doi.org/10.3389/fonc.2018.00156

Source records

crossref · retrieved 2026-09-26T10:51:52.262Z